Market Place
Sourcing Support
EC Approves KEYTRUDAPlus Trastuzumab and Chemotherapy as First-Line Treatment
29 Aug 2023 //
BUSINESSWIRE
FDA approves Taiho`s Lonsurf with bevacizumab for metastatic colorectal cancer
03 Aug 2023 //
ENDPTS
Merck’s KEYTRUDA Plus Chemotherapy Improved Overall Survival in GEJ
17 Feb 2023 //
PRESS RELEASE
Seagen Announces FDA Accelerated Approval of TUKYSA with Trastuzumab
19 Jan 2023 //
BUSINESSWIRE
Agilent Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include ESCC
05 Apr 2022 //
BUSINESSWIRE
European Commission approves Teysuno in metastatic colorectal cancer
31 Jan 2022 //
PRNEWSWIRE
BMS Receives European Commission Approval for Opdivo Plus Yervoy (ipilimumab)
29 Jun 2021 //
ONCLIVE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.